Skip to main content

View full-text article in PMC

. 2015 May 20;10(5):e0127404. doi: 10.1371/journal.pone.0127404

Table 2. Network meta-analysis comparison of the efficacy of the the 7 HER2-targeted treatment regimens for overall response rate (ORR).

T-DM1	0.59 (0.40,0.85) ^*	0.66 (0.42,1.02)	0.27 (0.17,0.43) ^*	0.45 (0.18,0.91) ^*	1.23 (0.66,2.11)	1.03 (0.53,1.76)
	LC	1.12 (0.97,1.42)	0.45 (0.36,0.58) ^*	0.75 (0.35,1.38)	2.06 (1.29,3.16) ^*	1.72 (0.99,2.81)
		HC	0.41 (0.33,0.52) ^*	0.67 (0.33,1.23)	1.85 (1.23,2.66) ^*	1.54 (0.89,2.42)
			NST	1.64 (0.77,3.01)	4.53 (2.79,6.94) ^*	3.80 (1.13,6.40) ^*
	ORR			PEC	3.04 (1.48,5.60) ^*	2.59 (1.25, 5.26) ^*
					PEHC	0.86 (0.45, 1.55)
						LHC

* The difference between A and B has statistical significance with its confidence interval without 1